Security key
74638P109
PURPLE BIOTECH LTD SPONSORED ADR - ADR (PPBT)
CUSIP: 74638P109
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / ADR
- Total 13F shares
- 15
- Total 13F value
- $70
- Share change
- 0
- SEC-reported price per share
- $4.67
- Number of holders
- 1
Report period
Q4 2024
Institutions
1
Top holders
1
PPBT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
PURPLE BIOTECH LTD. SEC filings
PURPLE BIOTECH LTD. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74638P109
Recent filing periods:
Ownership snapshot
Top reported holders of PPBT - PURPLE BIOTECH LTD SPONSORED ADR - ADR (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/11
Latest evidence
30 Sep 2024
13F
Highest disclosed value: $876,900
11 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
ARMISTICE CAPITAL, LLC has the largest disclosed position value at $876.9K.
0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 5
ARMISTICE CAPITAL, LLC
$876.9K
MORGAN STANLEY
$44.7K
BNP PARIBAS FINANCIAL MARKETS
$20.4K
Tower Research Capital LLC (TRC)
$1.4K
TD Waterhouse Canada Inc.
$1.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$876,900
158,000 shares
|
— | 30 Sep 2024 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$44,706
8,055 shares
|
— | 30 Sep 2024 |
| BNP PARIBAS FINANCIAL MARKETS |
13F
Company
|
—
denominator unverified
|
$20,396
3,675 shares
|
— | 30 Sep 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
—
denominator unverified
|
$1,415
254 shares
|
— | 30 Sep 2024 |
| TD Waterhouse Canada Inc. |
13F
Company
|
—
denominator unverified
|
$1,141
200 shares
|
— | 30 Sep 2024 |
| ROYAL BANK OF CANADA |
13F
Company
|
—
denominator unverified
|
$1,000
107 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
15
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q4 2025 Across Filers
Q4 2025 holders
1
Q4 2024 holders
1
Holder diff
0
| Investor | Q4 2025 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend